RE: Del...24 Aug 2017 13:39
JL....Tim over on ADVFN posted did just a few minutes ago.....
After the GKP disaster and the FTO dismal effort....I have dwindled out on any readies. One or the other at this point....
From Tim..
The re-financing documents are now available on the Sphere Medical web site:
http://www.spheremedical.com/investor-relations/shareholder-information/shareholder-communications
This one gives the terms for the convertible preference shares which look fairly standard to me
http://www.spheremedical.com/sites/default/files/Circular%20220817%20FINAL.PDF
The convertible preference shares have an 8% (compound) coupon, which is payable in additional preference shares. The effect of this will be to increase the potential dilution of the ordinary shares as time goes by, so for example the number of preference shares would double in the event that an IPO or trade sale occurred after 9 years, or they would increase by just under 50% (i.e. 47%) if an IPO or trade sale were to occur at 5 years.
In addition, the preference shares have preference over the ordinary shares when the company is sold (or liquidated). This preference would have no adverse effect on ordinary shareholders if the company were to be sold for a shed load (for example £100m) in a few years time, however, if the sale proceeds were to be only £5m (or less), Preference shareholders would receive all of the payment and ordinary shareholders would receive nothing.
Given that any new investment in Sphere Medical is likely to end up in a binary death or glory scenario, any PI contemplating a new investment in Sphere should consider buying the ordinary shares in the market at 1.1p or thereabouts, rather than subscribing for the preference shares (plus warrants) at 2.8p/ share.